Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (3): 402-407    DOI: 10.12892/ejgo4628.2019
Original Research Previous articles | Next articles
Impact of the human papillomavirus vaccination on patients who underwent conization for high-grade cervical intraepithelial neoplasia
P. Ortega-Quiñonero1, *(), M. Remezal-Solano2, M.C. Carazo-Díaz3, D. Prieto-Merino4, M.I. Urbano-Reyes5, L. García de Guadiana-Romualdo6, J.P. Martínez-Cendán7
1Department of Obstetrics and Gynecology, Santa Lucía University Hospital, Cartagena. Program of Doctorate in Health Sciences, Catholic University of Murcia (UCAM), Murcia, Spain
2Department of Obstetrics and Gynecology, Virgen de la Arrixaca University Hospital, Murcia. Catholic University of Murcia (UCAM), Murcia, Spain
3Applied Statistical Methods in Medical Research Group, Catholic University of Murcia (UCAM), Murcia, Spain
4Applied Statistical Methods in Medical Research Group, Catholic University of Murcia (UCAM), Murcia, Spain. Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom
5Department of Obstetrics and Gynecology, Santa Lucía University Hospital, Cartagena, Murcia, Spain
6Department of Biochemestry, Santa Lucía University Hospital, Cartagena, Murcia, Spain
7Department of Obstetrics and Gynecology, Santa Lucía University Hospital, Cartagena. Catholic University of Murcia (UCAM), Murcia, Spain
Download:  PDF(605KB)  ( 251 ) Full text   ( 12 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objectives: To test whether the human papillomavirus (HPV) vaccination in patients undergoing loop diathermy conization (LEEP) for high-grade intraepithelial neoplasia (CIN 2-3) is effective in preventing recurrence of CIN 2-3 in our area. Materials and Methods: A retrospective review was conducted on 242 patients undergoing LEEP for CIN 2-3 and 42.6% received the HPV vaccine (bivalent or tetravalent) immediately before or after conization. Follow up was conducted at 3, 6, 12, 18, and 24 months to detect CIN 2-3 recurrence. Results: Regardless of the HPV type, 27 (11.1%) patients developed CIN 2-3 recurrence during post-LEEP follow up. Of the 70 vaccinated with bivalent vaccine, two (2.8%) showed recurrence, of the 33 vaccinated with tetravalent vaccine, three (9%), and of the 139 unvaccinated 61 (43.9%) developed recurrence. Of the patients infected with HPV genotypes 16/18, in the non-vaccinated group, 15 (21.7%) patients had recurrence, whereas in the vaccinated group, three (5.9%) were diagnosed with recurrence (p < 0/05). The multivariate logistic regression analysis showed that the vaccination acted as a protective factor for CIN 2-3 recurrence (OR: 0.360 (95% CI: 0.125-1.000; p < 0.05). However, neither the type of vaccine nor the time of vaccination showed a significant association with the onset of recurrence. Conclusions: The HPV vaccine appears to be a recommendable preventative strategy in reducing the risk of recurrent disease for patients treated for CIN 2-3.

Key words:  Human papillomavirus      Vaccine      Cervical intraepithelial neoplasia      Recurrent disease      Conization      LEEP     
Published:  10 June 2019     
*Corresponding Author(s):  P. ORTEGA-QUIÑONERO     E-mail:  palogine@gmail.com

Cite this article: 

P. Ortega-Quiñonero, M. Remezal-Solano, M.C. Carazo-Díaz, D. Prieto-Merino, M.I. Urbano-Reyes, L. García de Guadiana-Romualdo, J.P. Martínez-Cendán. Impact of the human papillomavirus vaccination on patients who underwent conization for high-grade cervical intraepithelial neoplasia. European Journal of Gynaecological Oncology, 2019, 40(3): 402-407.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4628.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I3/402

[1] Qunying Wu, Jin-Ho Kuk, Young-Joon Ryu. A Distinct Human Papilloma Virus Epidemiological Profile of Korean-Chinese Women Living in Yanbian, China[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 753-761.
[2] Behiye Pinar Goksedef, Burak Giray, Canan Kabaca, Murat Ekmez, Sinan Gulec, Esra Keles, Isa Aykut Ozdemir, Suleyman Salman, Derya Sivri Aydin. Utility of colposcopy in the management of ASCUS and LSIL in women younger than 25-year-old: A retrospective multicenter study[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 685-688.
[3] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[4] Selçuk Kaplan. The role of p16 / Ki-67 dual staining in HPV positive and negative women in the early diagnosis of cervical precancerous lesions: Cytology, colposcopy and conization protocol[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 569-576.
[5] A.K. Fischer, K. Reuter-Jessen, H.-U. Schildhaus, T. Hugo, A.H. Scheel, S. Merkelbach-Bruse, E. Heinmöller, R. Buettner, B. Jasani, J. Walbeck, J.Rüschoff, P. Middel. Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 80-84.
[6] C. Chiappetta, C. Puggioni, E. Lendaro, J. Cacciotti, G. Migliore, P. Bellardini, V. Petrozza, C. Della Rocca, C. Di Cristofano. The hr-HPV based cervical cancer screening: results of a four-years experience in a single screening center of Italy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 932-938.
[7] J.-H. Kim, D.-Y. Kim. Imiquimod as an alternative option for young women with high-grade cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 943-947.
[8] R. Zivadinovic, D. Stankovic-Djordjevic, B. Zivadinovic, D. Krtinic, A. Petric, A. Zivadinovic, V. Radovanovic. How safe is a three-year screening interval for cervical cancer with conventional cytology in southeastern Serbia?[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1010-1018.
[9] E. Palma, M. Bertini. Vaginal microbiota and the pathobiosis path: its role in the evolution of HPV cervical intraepithelial neoplasia and cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 534-537.
[10] F. Salinaro, S. Loda, C. Schreiber, G. Ciravolo, G. Tisi, F. Ferrari, T. Maggino, F. Odicino, E. Sartori. LaserCO2 role in the treatment of vaginal intrepithelial neoplasia (VAIN) retrospective study involving 587 patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 538-542.
[11] Lili Qian, Zhen Shen, Xuefen Zhang, Dabao Wu, Ying Zhou. Fertility-sparing management for bulky cervical cancer with systemic chemotherapy and conization: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 684-687.
[12] J. Zhu , X. Wu, X. Liu. An evaluation of 721 women with Stage IA1 cervical cancer: is conservative surgical approach safe?[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 457-462.
[13] F. Liu, D.H. Hu, M.J. Fei, Y.F. Zhang, B. Wang, C.Y. Wang, K. Huang. Evaluation of p16/Ki67 dual staining compared with high-risk HPV testing to assess liquid-based cytology with atypical squamous cells of unknown significance[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 249-253.
[14] Aiping Fan, Chen Wang, Liqin Zhang, Ye Yan, Yingmei Wang, Cha Han, Fengxia Xue. The effect of different cervical transformation zone types on the colposcopic diagnosis of cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 290-294.
[15] R.J. Martinez-Portilla, M. Rial-Crestelo, M.A. Mejia-Ugarte, J.L. Lopez-Velazquez. Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 19-22.
No Suggested Reading articles found!